Canada Supreme Court upholds paliperidone dosing patent in Janssen dispute

The ruling says methods of medical treatment remain unpatentable in Canada, but finds the paliperidone dosing regimen falls outside that prohibition and can receive patent protection.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.